Cancer Genomic Medicine in Japan: Current Status and Future Perspectives
Authors: Sasaki, Rika; Takeda, Masayuki
Source journal: Internal medicine (Tokyo, Japan) (2026-11-19)
DOI: 10.2169/internalmedicine.8246-26
Abstract
Cancer genomic medicine (CGM) encompasses the integration of tumor genomic information into clinical decision-making. In Japan, comprehensive genomic profiling (CGP) is an essential component of CGM, as it facilitates the identification of actionable alterations, clinical trial enrollment, and treatment selection. Following the initiation of national insurance coverage in 2019, Japan has established a nationwide CGM network. However, clinical implementation remains limited by institutional restrictions, such as delayed testing and insufficient access to matched therapies. Recent evidence from CGP-guided therapies and expanding tumor-agnostic approvals, including those for trastuzumab deruxtecan for human epidermal growth factor receptor 2 (HER2)- positive solid tumors and alectinib for anaplastic lymphoma kinase (ALK) fusion-positive solid tumors, underscores the growing therapeutic relevance of molecular profiling and is expected to further accelerate precision oncology. This review summarizes recent advances in CGM that enable treatment selection based on molecular alterations beyond conventional tumor type-based approaches and discusses future directions considering the current healthcare system and challenges in Japan.
Related topics
Related open access articles
- PROFILE OF INTERLEUKIN-1β IN CERVICAL CANCER PATIENTS ATTENDING ONCOLOGY UNIT, USMANU DANFODIYO UNIVERSITY TEACHING HOSPITAL, SOKOTO-NIGERIA.
- Interaction profiling of growth hormone receptor and growth hormone proteins in Labeo rohita: an insight using molecular modelling and docking approaches
- Identification of ‘stress and Ca ++ metabolism related gene expression’ in wild Peromyscus exposed to environmental lead using combinatorial data from Mus cDNA microarrays and blood metabolites
- microRNA expression profiling in human diploid cells infected with enterovirus 71 or coxsackievirus A16
- Cellular bioelectric profiling: a novel method to differentially assess the in vitro toxicity of pesticides
- Profiling of bioactive lipids of the wild edible land snails of the genus Helix
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.